Methamphetamine

Group of students conversingMethamphetamine is a highly addictive central nervous system stimulant that alters the level of dopamine and increases reward-seeking behavior. Chronic and long-term use of methamphetamine can alter brain functioning leading to memory loss, poor decision-making, altered moods, and impulsivity, and can potentially damage the central nervous system. Methamphetamine use disorder is a complex brain disease affecting the well-being of users and the entire family. Treatment for methamphetamine use disorders is possible with active engagement, incentive-based approaches, and timely access to proper and structured treatment, including family-centered treatment.

Contact us at ncsacw@cffutures.org or 1(866) 493-2758 to learn more about methamphetamine use disorders and effective treatment options.

Policy and Practice Resources

  • Children Affected by Methamphetamine Program: Implementation Progress and Performance Measurement Report
  • Children Affected by Methamphetamine Program: Implementation Progress and Performance Measurement Report (PDF 1.69 MB)
    Substance Abuse and Mental Health Services Administration, 2016

    The report incorporates lessons learned from the SAMHSA-funded grant program that provided funding over a four-year period to 12 family treatment drug courts to improve the well-being, permanency, and safety outcomes of children, who are in, or at-risk of, out-of-home placement as a result of a parental methamphetamine or other substance abuse. This report includes lessons learned based on an integration of qualitative and quantitative findings, a summary of project design and implementation, and individual grantee performance organized by program priorities.

Related Webinars

  • Methamphetamine Abuse in Women of Reproductive Age
  • Practical Issues in the Implementation of the Matrix Model
    National Center on Substance Abuse and Child Welfare, 2014

    The Matrix Model is an intensive outpatient treatment approach for stimulant abuse and dependence that consists of relapse-prevention groups, education groups, social-support groups, individual counseling, and urine and breath testing delivered over a 16-week period. The webinar discusses implementation considerations and challenges, issues related to adaptation of the model, implementation drivers and challenges, fidelity monitoring, and measurement of impact and outcomes.

State and Local Examples

  • Reaching Out: Current Issues for Child Welfare Practice in Rural Communities
  • Reaching Out: Current Issues for Child Welfare Practice in Rural Communities (PDF 1.96 MB)
    University of California, Davis Center for Human Services, 2010

    Special Edition report on Round I of the Regional Partnership Grants in California. These grants were awarded to nine Northern California Counties to improve services to families in the child welfare system by bringing together child welfare, alcohol and other drug treatment services, and courts.

Additional Resources

  • Research Report Series: Methamphetamine
  • Research Report Series: Methamphetamine (PDF 2 MB)
    National Institute of Drug Abuse, 2013

    This publication provides an overview of methamphetamine use, effects, risks, and treatment effectiveness.
  • Meth360® Information Kit
  • Meth360® Information Kit (PDF 300 KB)
    The Partnership at Drugfree.org

    This kit provides six fact sheets about methamphetamine that discuss basic facts, effects of methamphetamine on users and communities, intervention and treatment, and family and community prevention strategies.

Related Research Articles

Prenatal Methamphetamine Exposure

Abar, B., LaGasse, L. L., Wouldes, T., Derauf, C., Newman, E., Shah, R.,... & Lester, B. M. (2014). Cross-national comparison of prenatal methamphetamine exposure on infant and early child physical growth: a natural experiment. Prevention Science, 15(5)), 767-776

Derauf, C., LaGasse, L. L., Smith, L. M., Newman, E., Shah, R., Neal, C. R.,… & Lester, B. M. et al. (2012). Prenatal methamphetamine exposure and inhibitory control among young school-age children. Journal of Pediatrics, 164(6), 1333-1338. doi:10.1016/j.jpeds.2014.01.053

Diaz, S. D., Smith, L. M., LaGasse, L. L., Derauf, C., Newman, E., Shah, R.,... & Arria, A. (2014). Effects of prenatal methamphetamine exposure on behavioral and cognitive findings at 7.5 years of age. Publication, 49-65.

Kiblawi, Z. N., Smith, L. M., LaGasse, L. L., Derauf, C., Newman, E., Shah, R.,… & Arria, A. (2013). The effect of prenatal methamphetamine exposure on attention as assessed by Continuous Performance Tests: Results from the Infant Development, Environment, and Lifestyle (IDEAL) Study. Journal of Developmental and Behavioral Pediatrics, 34(1), 31. doi:10.1097/DBP.0b013e318277a1c5

Kirlic, N., Newman, E., LaGasse, L. L., Derauf, C., Shah, R., Smith, L. M.,… & Arria, A. M. (2013). Cortisol reactivity in two-year-old children prenatally exposed to methamphetamine. Journal of Studies on Alcohol and Drugs, 74(3) , 447. From http://www.ncbi.nlm.nih.gov/pubmed/23490574 (accessed August 17, 2017).

LaGasse, L. L., Derauf, C., Smith, L. M., Newman, E., Shah, R., Neal, C.,… & Arria, A. et al. (2012). Prenatal methamphetamine exposure and childhood behavior problems at 3 and 5 years of age. Pediatrics, 129(4), 681-688. doi:10.1542/peds.2011-2209

Roos, A., & Donald, K. A. (2016). Refining the understanding of the effects of prenatal methamphetamine and tobacco exposure on the developing brain. JAMA Psychiatry, 73(12), 1228-1229. doi:10.1001/jamapsychiatry.2016.2845

Children and Families Affected by Methamphetamine

Akin, B. A., Brook, J., & Lloyd, M. H. (2015). Examining the role of methamphetamine in permanency: A competing risks analysis of reunification, guardianship, and adoption. American Journal of Orthopsychiatry, 85(2), 119-130.

Liles, B. D., Newman, E., LaGasse, L. L., Derauf, C., Shah, R., Smith, L. M.,… & Arria, A. M. (2012). Perceived child behavior problems, parenting stress, and maternal depressive symptoms among prenatal methamphetamine users. Child Psychiatry & Human Development, 43(6), 943-957. doi:10.1007/s10578-012-0305-2

Messina, N., & Jeter, K. (2012). Parental methamphetamine use and manufacture: Child and familial outcomes. Journal of Public Child Welfare, 6(3), 296-312. doi:10.1080/15548732.2012.683364

Pennar, A. L., Shapiro, A. F., & Krysik, J. (2012). Drug endangered children: Examining children removed from methamphetamine laboratories. Children and Youth Services Review, 34, 1777-1785. doi:10.1016/j.childyouth.2012.05.006

Rodi, M. S., Killian, C. M., Breitenbucher, P., Young, N. K., Amatetti, S., Bermejo, R., & Hall, E. (2015). New approaches for working with children and families involved in family treatment drug courts: Findings from the children affected by methamphetamine program. Child Welfare, 94(3).

Semple, S. J., Strathdee, S. A., Zians, J., & Patterson, T. L. (2011). Methamphetamine-using parents: The relationship between parental role strain and depressive symptoms. Journal of Studies on Alcohol and Drugs, 72(6), 954-964.

Treatment for Methamphetamine Use Disorder

Brensilver, M., Heinzerling, K. G., & Shoptaw, S. (2013). Pharmacotherapy of amphetamine‐ type stimulant dependence: An update.Drug and Alcohol Review, 32(5), 449-460. doi:10.1111/dar.12048

Ciketic, S., Hayatbakhsh, M. R., Doran, C. M., Najman, J. M., & McKetin, R. (2012). A review of psychological and pharmacological treatment options for methamphetamine dependence. Journal of Substance Use, 17(4), 363-383. doi:10.3109/14659891.2011.592900

Corsi, K. F., Garver-Apgar, C., & Booth, R. E. (2015). Contingency management and case management for out-of-treatment methamphetamine users. Drug & Alcohol Dependence, 146, e252

Cumming, C., Troeung, L., Young, J. T., Kelty, E., & Preen, D. B. (2016). Barriers to accessing methamphetamine treatment: A systematic review and meta-analysis. Drug & Alcohol Dependence, 168, 263-273.

Korcha, R. A., Polcin, D. L., Evans, K., Bond, J. C., & Galloway, G. P. (2014). Intensive motivational interviewing for women with concurrent alcohol problems and methamphetamine dependence. Journal of Substance Abuse Treatment, 46(2), 113-119

http://dx.doi.org/10.1016/j.jsat.2013.08.013 (accessed August 17, 2017).

Obert, J., McCann, M., & Rawson, R. A. (2015). Development and dissemination of the Matrix Model of intensive outpatient treatment. Textbook of Addiction Treatment: International Perspectives. , 961-971.

Roll, J. M., Chudzynski, J., Cameron, J. M., Howell, D. N., & McPherson, S. (2013). Duration effects in contingency management treatment of methamphetamine disorders.Addictive Behaviors, 38(9) , 2455-2462.

Smith, B. D. (2008). Methamphetamine use and child welfare: Review and research agenda. Journal of Public Child Welfare, 2(4) , 511-529.

Smout, M. F., Longo, M., Harrison, S., Minniti, R., Wickes, W., & White, J. M. (2010). Psychosocial treatment for methamphetamine use disorders: A preliminary randomized controlled trial of cognitive behavior therapy and acceptance and commitment therapy. Substance Abuse, 31(2), 98-107. doi:10.1080/08897071003641578

Svingen, L., Dykstra, R. E., Simpson, J. L., Jaffe, A. E., Bevins, R. A., Carlo, G.,… & Grant, K. M. (2016). Associations between family history of substance use, childhood trauma, and age of first drug use in persons with methamphetamine dependence. Journal of Addiction Medicine, 10(4) , 269-273.

Back to Top